As an Associate Consultant at Sia/ LBG, Ms. Compton brings a strong foundation in scientific innovation, and strategic problem-solving to life sciences consulting, drawing from extensive experience in medicinal chemistry and small molecule research within a large pharmaceutical organization. She supports LBG’s Government Services by assisting clients in navigating, securing, and managing non-dilutive funding. Further, Ms. Compton supports the development of technical solutions and proposals to the US Government, while also assisting with project management for awarded programs. Her passion for technical writing enhances her ability to translate complex scientific concepts into clear, compelling proposals that align with funding priorities. Additionally, Ms. Compton is highly skilled in visual presentation, creating polished, comprehensive materials that effectively communicate key information.
Before LBG, Ms. Compton worked as a medicinal chemist at Johnson & Johnson Innovative Medicine (JJIM), where she collaborated with scientists across diverse functions and therapeutic areas to develop new technologies, platforms, and workflows that enabled innovative chemistry and advanced small-molecule drug discovery. This experience strengthened her ability to navigate the complexities of research and development, from early discovery to pre-clinical evaluation.
Ms. Compton earned her Master’s degree in Organic Chemistry at the University of Pennsylvania under the mentorship of Professor Gary Molander. Funded by an NSF Graduate Research Fellowship awarded in her first year, her research focused on developing new methodologies at the interface of photoredox and nickel catalysis, as well as novel reagent design, leading to multiple publications in premier chemistry journals.